DCHS2 and neoplasm: The following genes with mutational overrepresentation in metastatic samples also qualified as early metastatic drivers: TP53, RB1, CTNNB1, and DCHS2. These genes might be suitable markers for disease progression, as they are likely metastatic drivers and they are already detectable in the primary tumor.